Patents by Inventor Eung Kweon Kim

Eung Kweon Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION FOR TREATING AVELLINO CORNEA DYSTROPHY COMPRISING AN ANTIBODY AGAINST TGF-BETA
    Publication number: 20100322947
    Abstract: The present invention relates to a medicine for treating Avellino corneal dystrophy (ACD), and more particularly, to a pharmaceutical composition for treating Avellino corneal dystrophy containing an antibody against TGF-? as an effective ingredient. The pharmaceutical composition of the present invention has an effect of improving symptoms of a patient with severe Avellino corneal dystrophy due to TGF-? induced by exposure to intense light, such as UV etc.
    Type: Application
    Filed: August 17, 2010
    Publication date: December 23, 2010
    Inventors: Eung Kweon Kim, Nae-Choon Yoo, Won-Min Yoo
  • DNA CHIP FOR DIAGNOSIS OF CORNEAL DYSTROPHY
    Publication number: 20090305394
    Abstract: The present invention relates to oligonucleotides for diagnosis of corneal dystrophy. More particularly, the present invention relates to oligonucleotides for detecting mutation of BIGH3 gene for diagnosis or corneal dystrophy including Avellino corneal dystrophy, which must be precisely diagnosed before vision correction surgery, and a DNA chip for diagnosis of corneal dystrophy, which has the oligonucleotides fixed thereon. According to the present invention, conventional microscopic diagnosis of corneal dystrophy can be replaced with a precise genetic method, which prevents a patient with corneal dystrophy from losing eyesight by eyesight correction surgery after erroneous diagnosis.
    Type: Application
    Filed: January 18, 2007
    Publication date: December 10, 2009
    Applicant: MEDIGENES CO., LTD.
    Inventors: Sang Yup Lee, So Young Yoo, Eung Kweon Kim, Ki-Chang Keum, Won-Min Yoo, Nae-Choon Yoo
  • Pharmaceutical Composition for Treating Avellino Cornea Dystrophy Comprising Blood Plasma or Serum
    Publication number: 20080299212
    Abstract: The present invention relates to a pharmaceutical agent for treating Avellino corneal dystrophy, and more particularly, to a pharmaceutical composition for treating Avellino corneal dystrophy comprising pharmaceutically effective amount of blood plasma or serum as an active ingredient. The pharmaceutical composition of the present invention has an effect of improving symptoms by dissolving away hyaline granules in the cornea of a patient with severe Avellino corneal dystrophy due to LASIK surgery.
    Type: Application
    Filed: February 24, 2006
    Publication date: December 4, 2008
    Applicant: MEDIGENES CO., LTD
    Inventors: Eung Kweon Kim, Nae-Choon Yoo, Won-Min Yoo
  • Pharmaceutical Composition for Treating Avellino Cornea Dystrophy Comprising an Antibody Against Tgf-Beta
    Publication number: 20080267946
    Abstract: The present invention relates to a medicine for treating Avellino corneal dystrophy (ACD), and more particularly, to a pharmaceutical composition for treating Avellino corneal dystrophy containing an antibody against TGF-? as an effective ingredient. The pharmaceutical composition of the present invention has an effect of improving symptoms of a patient with severe Avellino corneal dystrophy due to TGF-? induced by exposure to intense light, such as UV etc.
    Type: Application
    Filed: March 8, 2006
    Publication date: October 30, 2008
    Applicant: MEDIGENES CO., LTD
    Inventors: Eung Kweon Kim, Nae-Choon Yoo, Won-Min Yoo